Related Experiment Video
Updated: Jan 31, 2026

Live Cell Imaging of the TGF- β/Smad3 Signaling Pathway In Vitro and In Vivo Using an Adenovirus Reporter System
Published on: July 30, 2018
TGF-β Family Signaling Pathways in Cellular Dormancy
Chloé Prunier1, David Baker2, Peter Ten Dijke1
1Department of Cell and Chemical Biology and Oncode Institute, Leiden University Medical Center, Leiden, The Netherlands.
Cancer cells can enter a dormant state, resisting chemotherapy and causing relapse. Transforming growth factor-beta (TGF-β) signaling pathways are key to this dormancy, offering potential therapeutic targets to prevent cancer recurrence.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Cancer cells can reversibly enter a dormant, non-proliferative state.
- This dormancy is clinically significant as dormant cells resist chemotherapy, leading to potential cancer relapse.
- The molecular mechanisms of tumor cell dormancy are not fully understood.
Purpose of the Study:
- To review recent findings on the role of transforming growth factor-beta (TGF-β) signaling in cancer cell dormancy.
- To discuss the implications of TGF-β family signaling in the establishment, maintenance, and breaking of dormancy.
- To explore therapeutic strategies targeting TGF-β pathways to prevent cancer relapse.
Main Methods:
- Literature review of recent studies on TGF-β signaling and cancer dormancy.
- Analysis of evidence linking TGF-β family members to the regulation of cellular dormancy.
- Discussion of potential therapeutic interventions.
Main Results:
- Accumulating evidence indicates that TGF-β family signaling pathways are integral to cancer cell dormancy.
- TGF-β signaling plays a pivotal role in both the establishment/maintenance and the breaking of dormancy.
- Specific TGF-β pathways are implicated in the survival and resistance of dormant cancer cells.
Conclusions:
- TGF-β family signaling is a critical regulator of cancer cell dormancy.
- Targeting TGF-β pathways presents a promising strategy to overcome chemotherapy resistance and prevent cancer relapse.
- Further research into TGF-β-mediated dormancy mechanisms could lead to novel clinical treatments.
Related Concept Videos
TGF - β Signaling Pathway
Protein Families
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
Hedgehog Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Gene Families
Occasionally these regions can be adapted to take on new roles within the organism, becoming novel genes...

